Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Change in Accured Expenses (2021 - 2025)

Historic Change in Accured Expenses for P3 Health Partners (PIIIW) over the last 5 years, with Q3 2025 value amounting to -$2.8 million.

  • P3 Health Partners' Change in Accured Expenses rose 5626.06% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 11962.35%. This contributed to the annual value of -$8.1 million for FY2024, which is 15066.93% down from last year.
  • P3 Health Partners' Change in Accured Expenses amounted to -$2.8 million in Q3 2025, which was up 5626.06% from $5.0 million recorded in Q2 2025.
  • P3 Health Partners' 5-year Change in Accured Expenses high stood at $30.3 million for Q4 2021, and its period low was -$9.9 million during Q4 2024.
  • Its 5-year average for Change in Accured Expenses is $2.9 million, with a median of $2.5 million in 2023.
  • As far as peak fluctuations go, P3 Health Partners' Change in Accured Expenses soared by 48449.41% in 2023, and later plummeted by 36254.56% in 2024.
  • P3 Health Partners' Change in Accured Expenses (Quarter) stood at $30.3 million in 2021, then crashed by 94.97% to $1.5 million in 2022, then soared by 484.49% to $8.9 million in 2023, then crashed by 211.07% to -$9.9 million in 2024, then surged by 71.33% to -$2.8 million in 2025.
  • Its Change in Accured Expenses was -$2.8 million in Q3 2025, compared to $5.0 million in Q2 2025 and $5.6 million in Q1 2025.